SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Regency Hospital Ltd (526403) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 526403 NSE: | Hospital & Healthcare Services | Small Cap

BSE Share Price
Not Listed

Regency Hospital Ltd (526403)

BSE: 526403 NSE:
Key Metrics
Market Cap
₹49 Cr.
P/E Ratio
1.78
Price to Book (P/B)
1.21
Price to Sales (P/S)
0.13
EV/EBITDA
2.63
Return on Capital Employed (ROCE)
12.18%
Current Price
₹0
Return on Equity (ROE)
11.28%
Return on Assets (ROA)
5.06%
Operating Profit Margin
19.2%
Net Profit Margin
8.31%
Gross Profit Margin
17.1%
Book Value per Share
₹42.9
Sales Growth (YoY)
12.88%
Sales Growth (3 Years)
14.09%
Operating Profit Growth (1 Year)
5.54%
Operating Profit Growth (3 Years)
8.85%
Net Profit Growth (1 Year)
23.16%
52-Week Low / High
₹48 / 53
Net Profit Growth (3 Years)
18.02%
Dividend Yield
0.00%
Promoter Holding
71.12%
Pledged shares (%)
of Promoter's holding (%)
42.04%

DeciZen - make an informed investing decision on Regency Hospital

Based on:

M-Cap below 100cr DeciZen not available

Regency Hospital stock performance

Key Ratios
mw4me loader

Is an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 10.9%7.5%6.1%6.6%9.9%4.5%14.9%15.1%14.7%12.2%-
Value Creation
Index
-0.2-0.5-0.6-0.5-0.3-0.70.10.10.1-0.1-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 132149177226254263364424478540364
Sales YoY Gr.-12.5%19%27.7%12.2%3.8%38.1%16.8%12.7%12.9%-
Adj EPS 1.21.71.83.15.4-4.919.52126.13.329.2
YoY Gr.-45.2%7.2%72.6%73.5%-191.2%NA7.4%24.7%-87.5%-
BVPS (₹) 42.8100.598.6106.1111.4105.3124.1145.3266.928.742.9
Adj Net
Profit
1.12.32.44.37.5-6.927.429.536.748.227
Cash Flow from Ops. 15.218.923.623.445.431.682.285.556.875-
Debt/CF from Ops. 4.93.96.16.63.66.13.22.13.84.3-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 16.9%16.3%14.1%12.9%
Adj EPS 12.4%-9.4%-44.8%-87.5%
BVPS-4.4%-23.8%-38.6%-89.3%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
2.72.61.83.14.9-4.51715.612.612.181.5
Op. Profit
Mgn %
11.610.710.713.916.612.821.220.519.719.216.8
Net Profit
Mgn %
0.81.51.41.93-2.67.56.97.78.97.5
Debt to
Equity
1.90.51.111.11.31.50.90.60.81.3
Working Cap
Days
122128116108108124103919210265
Cash Conv.
Cycle
63463419191332135337

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials

Standalone Consolidated
TTM EPS (₹) 29.2 30.6
TTM Sales (₹ Cr.) 364 367
BVPS (₹) 42.9 183.7
Reserves (₹ Cr.) 31 163
P/BV 1.21 0.28
PE 1.78 1.70
From the Market
52 Week Low / High (₹) 48.10 / 52.90
All Time Low / High (₹) 0.70 / 108.00
Market Cap (₹ Cr.) 48.7
Equity (₹ Cr.) 9.4
Face Value (₹) 10
Industry PE 86.1

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *78.7857.760.000.000.000.000.000.000.0042.04
* Pledged shares as % of Promoter's holding (%)

Valuation of Regency Hospital - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales132.14148.69176.90225.95253.58263.17363.52424.46478.30539.89
Operating Expenses + 116.82132.71158.09194.59211.51229.53286.70337.71384.45440.84
Manufacturing Costs47.0852.4866.3879.1687.5697.49121.18136.96148.27162.07
Material Costs30.6334.9139.0549.7053.1463.0685.7199.99124.51144.71
Employee Cost 24.8530.4735.1041.1444.5547.0255.4967.3874.3783.34
Other Costs 14.2714.8517.5624.6026.2721.9724.3233.3837.3050.72
Operating Profit 15.3215.9718.8131.3542.0733.6476.8186.7493.8599.05
Operating Profit Margin (%) 11.6%10.7%10.6%13.9%16.6%12.8%21.1%20.4%19.6%18.3%
Other Income + 2.991.685.902.592.526.507.583.717.2913.98
Exceptional Items -0.8600-2000000
Interest 11.108.3611.2014.8917.0623.4821.6919.7324.1520.92
Depreciation 5.125.6010.011313.5825.1226.1528.2129.2031.62
Profit Before Tax 1.223.693.494.0513.94-8.4636.5642.5147.7960.50
Tax 0.751.441.151.216.48-1.519.2613.1211.3515.62
Profit After Tax 0.482.252.352.847.46-6.9527.3029.3936.4444.88
PAT Margin (%) 0.4%1.5%1.3%1.3%2.9%-2.6%7.5%6.9%7.6%8.3%
Adjusted EPS (₹)0.51.71.82.05.3-5.019.420.926.03.1
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 40.09135.17132.63148.97156.43147.82174.33204.10377.03421.20
Share Capital 9.3613.4513.4514.0414.0414.0414.0414.0416.32146.88
Reserves 30.73121.73119.18134.93142.39133.78160.29190.06360.71274.32
Debt +64.5464.21129.99140.78156.11175.36175.57156.82188.32293.49
Long Term Debt50.5856.38115.13123.33130.87162.70148.95132.86163.28280.14
Short Term Debt13.967.8214.8717.4625.2312.6626.6223.9625.0513.35
Minority Interest0000000000
Trade Payables10.9215.2318.6427.9925.2029.0924.3933.5232.1743.71
Others Liabilities 29.8035.9974.0469.9983.19115.45201.30129.87147.49269.37
Total Liabilities 145.36250.60355.30387.74420.93467.73575.59524.30745.021,027.77

Fixed Assets

Net Fixed Assets +77.0191.04258.09255.61266.05343.85341.72333.60330.40453.74
Gross Block104.89122.50298.78308.63332.20369.26393.02412.90437.38590.52
Accumulated Depreciation27.8831.4640.7053.0266.1525.4151.3179.30106.99136.78
CWIP 3.3613.369.9135.3751.796.929.7542.73119.48298.37
Investments 9.7390.456.146.644.551.9228.661.85140.60101.88
Inventories4.855.237.709.1510.7910.2811.2512.7313.4214.86
Trade Receivables26.4432.2527.2737.1736.8722.4029.8368.5779.3686.91
Cash Equivalents 2.613.7221.1416.7822.1812.8991.6139.3519.966.42
Others Assets 21.3614.5525.0727.0128.6969.4662.7725.4741.8065.59
Total Assets 145.36250.60355.30387.74420.93467.73575.59524.30745.021,027.77

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + 15.2418.9423.6423.4245.3931.5882.1685.5356.8075.04
PBT 1.223.693.494.0513.94-8.4636.5642.5147.7960.50
Adjustment 20.7717.5920.8534.5934.7649.1045.0454.9356.9957.29
Changes in Working Capital -4.280.12-0.69-13.080.69-12.773.17-6.03-32.35-26.52
Tax Paid -2.48-2.46-0.02-2.15-4.013.71-2.60-5.88-15.63-16.23
Cash Flow From Investing Activity + -18.12-101.24-82.30-21.01-56.45-25.01-49.65-31.21-228.35-158.69
Capex -17.03-19.86-147.85-38.13-40.48-30.50-26.96-56.43-87.80-216.74
Net Investments -1.11-81.3970.2916.53-16.042.87-26.4423.16-141.5656.97
Others 0.020.01-4.740.590.072.623.752.061.011.08
Cash Flow From Financing Activity + -0.5982.7459.109.94-2.513.7046.20-110.38144.9780.30
Net Proceeds from Shares 092.83013.50000000
Net Proceeds from Borrowing 11.104.1862.817.803.8600-81.2634.19118.69
Interest Paid -11.65-8.13-10.76-13.95-14.15-20.99-18.40-19.19-18.91-18.03
Dividend Paid 0000000000
Others -0.04-6.147.042.597.7724.7064.61-9.94129.69-20.36
Net Cash Flow -3.470.440.4412.35-13.5710.2878.72-56.06-26.58-3.36

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)1.22.571.752.024.89-4.5716.9515.5312.5911.28
ROCE (%)10.897.456.076.559.944.5314.9415.1114.7212.18
Asset Turnover Ratio0.990.750.580.610.630.590.70.770.750.61
PAT to CFO Conversion(x)31.758.4210.068.256.08N/A3.012.911.561.67
Working Capital Days
Receivable Days68726152534126425656
Inventory Days15121314141511101010
Payable Days711371581711831571141069696

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Regency Hospital Ltd FAQs

The current trading price of Regency Hospital on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Regency Hospital stood at ₹48.67 Cr

The latest P/E ratio of Regency Hospital as of 31-Dec-1969 is 1.78.

The latest P/B ratio of Regency Hospital as of 31-Dec-1969 is 1.21.

The 52-week high of Regency Hospital is ₹52.90 and the 52-week low is ₹48.10.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Regency Hospital is ₹364 ( Cr.) .

About Regency Hospital Ltd

Regency Hospital is the first, Multi Specialty Tertiary Care Corporate hospital in Uttar Pradesh, which was established in 1995 with a view to fill the wide gap between the demand of high class medical services and actually available services thereof.

The hospital was established in technical consultancy with Indian Hospital Corporation, Hyderabad. Regency Hospital is a public company which is listed at BSE and UPSE. RHL provides round the clock emergency services with in-patient and out-patient facilities. Regency Hospital is designed to serve the entire gamut of medical needs of the nation and beyond, through a network of specialized healthcare facilities across Kanpur.

The hospital has ICU, ICCU and NICU, PICU bedsides General Wards, Semi- Private, Deluxe and Super Deluxe Rooms. The hospital is centrally Air-Conditioned including General Wards. The patients are provided with hygiene meal under the supervision of dieticians.

The aim is to provide the patient with easily accessible, comprehensive and consistent quality healthcare, with a special focus on patient care. Hence we have a number of specialized Team to help us achieve this task.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×